Grants
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

For Researchers looking for funding: Contact us at 888-295-4740 to discuss your project before submitting an application. Click HERE for the grant application. Grant applications may be submitted at any time. We have 2 granting rounds per year, with deadlines of May 15 and Dec 15; however, in some cases we may be able to approve grants between rounds.

Our recent grant awards include:

  • 2014
    • $5,000 to the Central Brain Tumor Resigtry of the United States to help further their vital mission of gathering and disseminating brain tumor epidemiologic data
    • $50,000 to Dr. Manmeet Ahluwalia, Cleveland Clinic, for the project: "Phase 1 trial of Ganetespib with Radiation and Temozolomide in Patients With Newly Diagnosed High Grade Glioma"
    • $25,000.00 to Dr. Ahluwalia at Cleveland Clinic Neuro-oncology Center for project: Microparticles in Phase 1 trial of Ganetespib with Temozolomide in Patients with High Grade Glioma
    • $50,000.00 to Dr. Schwartz, MD, Phd at Hackensack University Medical Center for project: Effect of decreased hypoxia and kinase activity on radiotherapyof GL261-luc tumors
    • $5,000.00 to Dr. Kwatra at Duke University Medical Center for project: Isolation, characterization and effect of EGFR inhibitors on stem cells from patient-derived glioblastoma xenografts
    • $25,000.00 to Dr. Allen at Oncoceutics for project: Target Identification of ONC201, a First-in-Class Drug to Treat Glioblastoma
    • $50,000.00 to Dr. Prins and Dr.Linda Liau at UCLA for project: Role of the PD-1/PD-L1 co-stimulatory axis for immunotherapy of glioma
    • $10,000.00 to Dr. Linskey at University of California, Irvine for project: Establishing an In Vivo Human Glioma Resection Model for Testing and Validating therapeutic effect of EFEMP1-derived Tumor Suppressive Protein
    • $50,000.00 to Dr. Cobbs at Swedish Medical Center for project: Establishment of a Reference Laboratory for Cytomegalovirus and Other Viral Infections in Glioblastoma
    • $50,000.00 to Dr. Cohen at University of Utah for project: Phase 1 trial in Newly Diagnosed High Grade Glioma with Temozolomide, Radiation, and Minocycline followed by Adjuvant Minocycline/Temozolomide. (D-TERMINED)
  • 2013
    • $99,982.00 to Dr Bong Seop Lee and Dr John Yu at Cedars-Sinai Medical Center for the project "Targeted brain tumor treatment using TQM-CPT nanoprodrug recognizing tumor-specific IL13Ra2 mutant "
    • $10,000 to Dr Madon Kwatra of Duke University for project: Isolation of stem cells from glioblastoma xenografts with activated EGFR
    • $30,000 to Dr Towner for: Anti-Cancer Activity of OKN-007 in Pediatric Gliomas (Sponsored in part by by the National Walk To End Brain Tumors)
    • $84,000 to Dr Okada, University of Pittsburgh, for a Low Grade Glioma Vaccine trial.(Sponsored by the National Walk To End Brain Tumors)
    • $4,000 to Dr. Nazarian of the Children's Research Institute in Washington, DC for the project titled:"Collection of Autopsy DIPG Specimens".(Sponsored in part by the "Save to Shave" Fundraiser and the National Walk To End Brain Tumors)
    • $50,000 to Dr. Nazarian of the Children's Research Institute in Washington, DC for the project titled:"Emerging Methods for Treating Pediatric Brain Tumors". (Sponsored in part by the "Save to Shave" Fundraiser the National Walk To End Brain Tumors)
  • 2012
    • $30,000 to Dr Okada, University of Pittsburgh, for a follow up study on his vaccine trials for adult and pediatric high and Low Grade Glioma / Oligodendroglioma vaccine trials.
    • $40,000 to Dr Okada, University of Pittsburgh, for a Low Grade Glioma Vaccine trial.
    • $50,000 to Tocagen, Inc, to support the clinical investigation of Toca 511 & Toca FC in patients with recurrent Grade 3 glioma brain cancer.
    • $8,000 to Dr. Nazarian of the Children's Research Institute in Washington, DC for the project titled:"Collection of Autopsy DIPG Specimens".
    • $36,015 to Dr. Yi-Hong Zhou - UC Irvine for project: "Development of a tumor suppressive extracellular signaling peptide to treat GBM.". Click HERE for the published paper
    • $35,000 to Targepeutics, Inc for the Development of GB-13 as a Novel Glioblastoma Therapy
  • 2011
    • $60,000 to Drs. Raychaudhuri and Vogelbaum at the Cleveland Clinic for project titled: Immunosuppressive and Pro-Angiogenic Effects of Myeloid Derived Suppressor Cells in Patients with Glioblastoma
    • $50,000 to Hideho Okada M.D., Ph.D. at the Pittsburgh Cancer Center for basic research on vaccine therapies for all types of brain tumors including low and high grade, as well as meatastatic breast cancer. [Funds provided by the National Walk To End Brain Tumors!] Click HERE for one of the articles that resulted from this grant!
    • Another $5,000 for "Collection of Autopsy DIPG Specimens" by Dr Javad Nazarian at the Children's Research institute in Washington, DC [For final report of previous grant, click here!] [ Funded with proceeds of the National Walk to End Brain Tumors!]
    • $5,000 (our portion) to Dr. F. Avraham Dilmanian at Brookhaven National Lab, NY, for the project: "Carbon Ion Microbeam Radiation Therapy of High Grade Gliomas". We partnered with Stony Brook Medical School and the Stony Brook University to award this $80,000 grant. Abstract of results
    • $2,000 to the Weill Cornell Medical College Dept Neurological Surgery for the project: "Targeted Radio-Immunotherapy for Malignant Brainstem Glioma"
    • $20,000 to Dr Jim Olsen, University of Washington/Fred Hutchinson Cancer Center, for project: In vivo prioritization of FDA drugs for Brainstem gliomas. Funded with proceeds of the National Walk to End Brain Tumors!
  • 2010
    • $28,000 to Dr Rolf F. Barth for the project: "Chemoradiotherapy of High Grade Gliomas Using Convection Enhanced Delivery of Carboplatin in Combination with X-irradiation"
    • $10,000 to Targepeutics, Inc, for the manufacturing and testing of GB-13,
    • $38,000 to Dr Jim Olsen, University of Washington/Fred Hutchinson Cancer Center, for project: In vivo prioritization of FDA drugs for PNET brain tumors. Funded via the Grey Ribbon Crusade in conjunction with Unlocking Brain Tumors and Have A Chance, Inc
    • $25,000 to Dr. F. Avraham Dilmanian at Brookhaven National Lab, NY, for the project: "Heavy Ion Microbeam Radiation Therapy of High Grade Gliomas". Funded via the Grey Ribbon Crusade in conjunction with Unlocking Brain Tumors and Have A Chance, Inc
    • $50,000 to Dr Darell Bigner at Duke for the project: Novel Single Chain Trispecific Immunotoxin D2C7-Mel-14 for GBM Therapy. Funded via the Grey Ribbon Crusade in conjunction with Unlocking Brain Tumors and Have A Chance, Inc
    • $5,000 for "Collection of Autopsy DIPG Specimens" by Dr Javad Nazarian at the Children’s Research institute in Washington, DC [For final report, click here!]
  • 2009
    • $10,000 to the Brad Kaminsky Foundation - part of the Grey Ribbon Crusade - to help pay for the 2009 race for hope which will support brain tumor vaccine research!
    • $40,000 to Dr Rahman at the University of Florida for project titled: "Morphogenetic Protein + Avastin in the Treatment of Glial Tumors". This was funded through the Grey Ribbon Crusade with the help of Unlocking Brain Tumors.
    • $10,000 to Dr Rahman at the University of Florida for project titled:"Bone Morphogenetic Protein in the Treatment of Glial Tumors". This was funded through the Grey Ribbon Crusade with the help of our Oligo Fund, Just One More Day for Love, Hope & a Cure and Gunner's Magic Train Pediatric Cancer Foundation. Click HERE for the results presented as a poster at the Society For Neuor-oncology conference in New Orleas Oct 2009
    • $20,000 contribution as part of a $70,000 Grey Ribbon Crusade grant to F. Avraham Dilmanian, Ph.D. at Brookhaven National Lab, NY for the project titled: "Treating Brain tumors with lnterlaced Carbon Microbeams"
    • $40,000 to Dr Deneen at the Center for Cell and Gene Therapy at Baylor College of Medicine for project: "The role of glial fate determinants in the generation of astrocytomas". This was funded through the Grey Ribbon Crusade with the help of the Nick Gonzales Foundation!
    • $49,938 to Dr Zagzag at NYU Medical Center for 2 projects: 1. Combined Anti-Angiogenic and Anti-Invasive Therapy for Gliomas. 2. Evaluation of R132H-mutation of isocitrate dehydrogenase-1 and HIF-1a upregulation in adult glioma. [Results: First page only (email us for the full text. We can not display it on the website)] This grant was funded by our "Donald Klein Memorial Fund", individual donations as well as a generous donation from Unlocking Brain Tumors via the Grey Ribbon Crusade!
    • $17,000 to Dr Barth at Ohio State for project: Preclinical Studies on Convection Enhanced Delivery of Carbolatin in Combination with Photon Irradiation for the Treatment of Gliomas. This was funded via a generous grant to us from the Have a Chance foundation, and represented the second half of a project started last year.
    • $50,000 to Dr Barth at Ohio State for project: Preclinical Study on Convection Enhanced Delivery of Carbolatin in Combination with Photon Irradiation for the Treatment of high grade Gliomas. This was funded via the Grey Ribbon Crusade with help from the Nick Gonzales Foundation! Click here for the final report on the results.
    • $5,000 to Dr Michael J. Gilman,PhD, Data Mining Technologies Inc. for analysis of the brain tumor virtual trial data.
    • $50,000 to Dr Jose Valerio at the the Cleveland Clinic for project: Targeting metabolism in brain tumors
  • 2008
    • $5,000 to the Brad Kaminsky Foundation (as part of the Grey Ribbon Crusade) - for project: Preclinical Studies on Convection Enhanced Delivery of Carbolatin in Combination with Photon Irradiation for the Treatment of Gliomas
    • $8,000 to the Brad Kaminsky Foundation (as part of the Grey Ribbon Crusade) - for project: Heroes of Hope Race for Research to raise money for the immunotherapy program at UCLA
    • $20,000 to the Brad Kaminsky Foundation (as part of the Grey Ribbon Crusade) - for project: Preclinical Studies on Convection Enhanced Delivery of Carbolatin in Combination with Photon Irradiation for the Treatment of Gliomas
    • $10,000 to the Pediatric Brain Tumor Program at Columbia Presbyterian Medical Center, NY for project involving Ruta-6 in rats.
    • $20,000 to Dr Muh at Emory for project titled :A novel pan PI3-kinase inhibitor (SF1126) in the treatment of medulloblastoma. This was the first grant given via the Heroes of Hope coalition, where brain tumor organizations work together to quickly fund projects. Our contribution for this project was $6,667. The Wittmer Foundation and Unlocking Brain Tumors, Inc each also contributed $6,667.
    • $60,000 to Dr Hideho Okada at the University Of Pittsburgh for work on a new vaccine for low grade oligodendrogliomas. Click HERE for a video about his current vaccine for GBMs This grant was made possible through the Oligo Fund, and the Heroes Of Hope coalition (greyribboncrusade.org), specifically, with the help of Unlocking Brain Tumors, George Bein and the Oligo online support group!
  • 2007
    • $40,000 to Dr Hideho Okada at the University Of Pittsburgh for work on a new vaccine for low grade glioma. Click HERE for a video about his current vaccine for GBMs
    • $25,000 grant to F. Avraham Dilmanian, Ph.D. at Brookhaven National Lab, NY for the project titled: "Stereotactic Microbeam Radiation Therapy of a rat brainstem gliosarcoma as a surrogate for optic glioma" - (This was the 4th payment for a project started Dec 2006)
    • $25,000 grant to F. Avraham Dilmanian, Ph.D. at Brookhaven National Lab, NY for the project titled: "Stereotactic Microbeam Radiation Therapy of a rat brainstem gliosarcoma as a surrogate for optic glioma" - (This was the third payment for a project started Dec 2006). Click HERE to see an article about the project.
    • $20,000 grant to F. Avraham Dilmanian, Ph.D. at Brookhaven National Lab, NY for the project titled: "Stereotactic Microbeam Radiation Therapy of a rat brainstem gliosarcoma as a surrogate for optic glioma" - (This was the second payment for a project started Dec 2006)
  • 2006
    • $15,000 grant to F. Avraham Dilmanian, Ph.D. at Brookhaven National Lab, NY for the project titled: "Stereotactic Microbeam Radiation Therapy of a rat brainstem gliosarcoma as a surrogate for optic glioma" - Note: this grant was a joint effort between the Musella Foundation and the Lauren's First and Goal Foundation
    • $50,000 to Robert Prins. PhD, at UCLA Medical Center, for the project titled: “Genetic profiling and immunotherapeutic targeting of Optic Gliomas”
    • $50,000 to Timothy E. Van Meter, PhD at Virginia Commonwealth University for a project entitled "A Molecular Signature of Pediatric Optic Glioma"
  • 2005
    • $80,000 grant to Dr Linda Liau at UCLA start a phase 1 trial of recombinant Listeria Monocytogenes (rLM) live bacterial vectors for targeting tumor-associated antigens expressed by malignant gliomas that are otherwise inoperable
    • $150,000 milestone payment toward $500,000 grant to Cedar Sinai for "A Phase I Trial of Tumor Associated Antigen-Pulsed Dendritic Cell Immunotherapy for Patients with Brain Stem Glioma" - to start the trial on patients! Previous portion of grant was for creation of the vaccine therapy.
    • $10,000 to Dr. Garret Yount at the California Pacific Medical Center Research Institute for project: "Brain Tumor Stem Cell Response to Novel Anti-Cancer Agents"
    • $10,000 to Dr. Peter Burger and Dr. Charles Eberhart at the Johns Hopkins School Of Medicine, for Pilomyxoid / Pilocytic Research Study. Other organizations are working together with us to fund this $60,000 project!
  • 2004
    • $120,000 to Dr Linda Liau at UCLA for the Development of recombinant Listeria Monocytogenes (rLM) live bacterial vectors for targeting tumor-associated antigens expressed by malignant gliomas (including Diffuse Intrinsic Pontine Gliomas) that are otherwise inoperable.*
    • $500,000 was awarded to Dr Keith Black and Dr John Yu at Cedas Sinai for "A Phase I Trial of Tumor Associated Antigen-Pulsed Dendritic Cell Immunotherapy for Patients with Brain Stem Glioma" , which will pay for the first 2 years of a possible 4 year study. First payment of $100,000 was made.
    • $50,000 to Dr Roberta Hayes at Cabrini Medica Center for "Generation of an Immunologic Vaccine against EGFR mutants for inoperable brain tumors: brainstem gliomas and gliomatosis"
    • $50,000 to Dr. Kellie J. Nazemi and the Dana-Farber Cancer Institute for "Investigation into the Pathways that Regulate Growth of Infratentorial (brainstem) Brain Tumors"
    • $30,000 to Dr. Erwin VanMeir at the Winship Cancer Institute at Emory University for "Investigation of the role of IL-8 expression in gliomagenesis"
  • 2003
    • $50,000 to Dr. Waldemar Debinski for pre-clinical work on Glioblast-13, a new IL-13-based cytotoxin for malignant glioma.
    • $40,000 to Dr. Paul Zeltzer to research a book on brain tumors for patients
    • $6,000 to Dr. Roberta Hayes to purchase a freezer used to store cell cultures for an immunotherapy research project (IL-2 + LAK Cells).

Totals: 60 grants for $2,380,935.00


* means that we are managing the grant, but the money is coming directly from an individual or another organization.

Grants waiting for funding

We have many grant requests sitting on our desk just waiting for funding. All of these have the potential to make a major impact in this disease and we need YOUR help to get them funded!



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2014 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites